These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 17235714
21. Blockade of the epidermal growth factor receptor signaling inhibits angiogenesis leading to regression of human renal cell carcinoma growing orthotopically in nude mice. Kedar D, Baker CH, Killion JJ, Dinney CP, Fidler IJ. Clin Cancer Res; 2002 Nov; 8(11):3592-600. PubMed ID: 12429651 [Abstract] [Full Text] [Related]
22. Calreticulin: a potential diagnostic and therapeutic biomarker in gallbladder cancer. Ye J, Qi L, Du Z, Yu L, Chen K, Li R, Feng R, Zhai W. Aging (Albany NY); 2021 Feb 11; 13(4):5607-5620. PubMed ID: 33591948 [Abstract] [Full Text] [Related]
23. Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases. Solorzano CC, Baker CH, Bruns CJ, Killion JJ, Ellis LM, Wood J, Fidler IJ. Cancer Biother Radiopharm; 2001 Oct 11; 16(5):359-70. PubMed ID: 11776753 [Abstract] [Full Text] [Related]
24. A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma. Eng C, Ramanathan RK, Wong MK, Remick SC, Dai L, Wade-Oliver KT, Mani S, Kindler HL. Am J Clin Oncol; 2004 Dec 11; 27(6):565-9. PubMed ID: 15577433 [Abstract] [Full Text] [Related]
25. Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo. Wang ZH, Chen H, Guo HC, Tong HF, Liu JX, Wei WT, Tan W, Ni ZL, Liu HB, Lin SZ. Int J Oncol; 2011 Nov 11; 39(5):1123-31. PubMed ID: 21743963 [Abstract] [Full Text] [Related]
26. Gemcitabine suppresses malignant ascites of human pancreatic cancer: correlation with VEGF expression in ascites. Kuwahara K, Sasaki T, Kobayashi K, Noma B, Serikawa M, Iiboshi T, Miyata H, Kuwada Y, Murakami M, Yamasaki S, Kariya K, Morinaka K, Chayama K. Oncol Rep; 2004 Jan 11; 11(1):73-80. PubMed ID: 14654905 [Abstract] [Full Text] [Related]
27. Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. Ahn DW, Seo JK, Lee SH, Hwang JH, Lee JK, Ryu JK, Kim YT, Yoon YB. Pancreas; 2012 Oct 11; 41(7):1048-57. PubMed ID: 22513291 [Abstract] [Full Text] [Related]
28. A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma. Lin LL, Picus J, Drebin JA, Linehan DC, Solis J, Strasberg SM, Tan B, Thorstad WL, Myerson R. Am J Clin Oncol; 2005 Jun 11; 28(3):234-41. PubMed ID: 15923794 [Abstract] [Full Text] [Related]
29. Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice. Kim IY, Kang YS, Lee DS, Park HJ, Choi EK, Oh YK, Son HJ, Kim JS. J Control Release; 2009 Nov 16; 140(1):55-60. PubMed ID: 19616596 [Abstract] [Full Text] [Related]
30. In vivo chemotherapeutic profile of human gallbladder small cell carcinoma. Nishime C, Ohnishi Y, Suemizu H, Tamaoki N, Kusumi T, Sato F, Yamazaki H, Nakamura M, Ueyama Y, Kijima H. Biomed Res; 2008 Oct 16; 29(5):251-6. PubMed ID: 18997440 [Abstract] [Full Text] [Related]
31. Phenoxodiol enhances the antitumor activity of gemcitabine in gallbladder cancer through suppressing Akt/mTOR pathway. Li Y, Huang X, Huang Z, Feng J. Cell Biochem Biophys; 2014 Nov 16; 70(2):1337-42. PubMed ID: 24902539 [Abstract] [Full Text] [Related]
32. Induction of Metastasis by Low-dose Gemcitabine in a Pancreatic Cancer Orthotopic Mouse Model: An Opposite Effect of Chemotherapy. Sugisawa N, Miyake K, Higuchi T, Oshiro H, Zhang Z, Park JH, Kawaguchi K, Chawla SP, Bouvet M, Singh SR, Unno M, Hoffman RM. Anticancer Res; 2019 Oct 16; 39(10):5339-5344. PubMed ID: 31570427 [Abstract] [Full Text] [Related]
33. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas. Abdel-Rahman O, Elsayed Z, Elhalawani H. Cochrane Database Syst Rev; 2018 Apr 06; 4(4):CD011746. PubMed ID: 29624208 [Abstract] [Full Text] [Related]
34. Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice. Yezhelyev MV, Koehl G, Guba M, Brabletz T, Jauch KW, Ryan A, Barge A, Green T, Fennell M, Bruns CJ. Clin Cancer Res; 2004 Dec 01; 10(23):8028-36. PubMed ID: 15585638 [Abstract] [Full Text] [Related]
38. Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer. Liu D, Kojima T, Ouchi M, Kuroda S, Watanabe Y, Hashimoto Y, Onimatsu H, Urata Y, Fujiwara T. Mol Cancer Ther; 2009 Apr 01; 8(4):980-7. PubMed ID: 19372571 [Abstract] [Full Text] [Related]
39. Efficacy of gemcitabine in the treatment of patients with gallbladder carcinoma: a case report. Castro MP. Cancer; 1998 Feb 15; 82(4):639-41. PubMed ID: 9477094 [Abstract] [Full Text] [Related]
40. Therapeutic Effects of Microbubbles Added to Combined High-Intensity Focused Ultrasound and Chemotherapy in a Pancreatic Cancer Xenograft Model. Yu MH, Lee JY, Kim HR, Kim BR, Park EJ, Kim HS, Han JK, Choi BI. Korean J Radiol; 2016 Feb 15; 17(5):779-88. PubMed ID: 27587968 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]